Advertisement
Advertisement

PYXS

PYXS logo

Pyxis Oncology, Inc. Common Stock

1.53
USD
Sponsored
-0.01
-0.32%
Feb 06, 15:58 UTC -5
Closed
exchange

After-Market

1.54

+0.01
+0.33%

PYXS Earnings Reports

Positive Surprise Ratio

PYXS beat 7 of 17 last estimates.

41%

Next Report

Date of Next Report
Mar 16, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.34
Implied change from Q3 25 (Revenue/ EPS)
--
/
-2.86%
Implied change from Q4 24 (Revenue/ EPS)
--
/
+36.00%

Pyxis Oncology, Inc. Common Stock earnings per share and revenue

On Nov 03, 2025, PYXS reported earnings of -0.35 USD per share (EPS) for Q3 25, missing the estimate of -0.34 USD, resulting in a -1.36% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.02% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 11 analysts forecast an EPS of -0.34 USD, with revenue projected to reach -- USD, implying an decrease of -2.86% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Takeda Pharmaceutical Company Limited - ADR
Report Date
Jan 30, 2026 For Q3 26
Estimate
$34.44
Actual
$65.64
Surprise
+90.61%
FAQ
For Q3 2025, Pyxis Oncology, Inc. Common Stock reported EPS of -$0.35, missing estimates by -1.36%, and revenue of $0.00, 0% as expectations.
The stock price moved up 7.02%, changed from $3.56 before the earnings release to $3.81 the day after.
The next earning report is scheduled for Mar 16, 2026.
Based on 11 analysts, Pyxis Oncology, Inc. Common Stock is expected to report EPS of -$0.34 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement